KURA ONCOLOGY, INC. (KURA) Operating income 2022–2025
KURA ONCOLOGY, INC. (KURA) annual operating income history from SEC filings — each fiscal year as reported.
-$303.6MFY2025 · since FY2022: -$139.9M → -$303.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$303.6M | -57.2% |
| FY2024 | -$193.2M | -16.5% |
| FY2023 | -$165.8M | -18.5% |
| FY2022 | -$139.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More KURA financial trends
KURA RevenueKURA Net incomeKURA Net marginKURA Gross profitKURA Gross marginKURA Operating marginKURA Operating cash flowKURA Free cash flowKURA Capital expendituresKURA Return on equityKURA Stock buybacksKURA Dividends paidKURA Total assetsKURA Total liabilitiesKURA Shareholders’ equityKURA overview →